Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUNCET low-sodium oxybate for nocturnal chronic cluster headache
NL-OMON61357Phase 2Not yet recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Cluster Headache (CH) comparing Xywav with Placebo (2 arms). Primary endpoint: Change in average weekly frequency of nocturnal cluster headache attacks. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
sodium oxybate + calcium oxybate + potassium oxybate + magnesium oxybate
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NL-OMON61357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61357.